Literature DB >> 2966190

Rebound increase in plasma renin and vasopressin following graded infusions of atrial natriuretic peptide in man.

T D Williams1, K P Walsh, E Pitts, R Sutton, S L Lightman.   

Abstract

The effects of graded infusions of atrial natriuretic peptide (ANP) on hemodynamics, renal function, plasma renin activity (PRA) and plasma arginine vasopressin (AVP) were investigated in a two part study in 6 volunteers. Three 30-min iv infusions of either saline control or ANP at graded rates of 4, 10 and 40 pmol kg-1 min-1 were given. ANP infusions were associated with a significant increase in sodium clearance from 1.08 +/- 0.21 to 2.83 +/- 0.50 ml/min, an increase in hematocrit and a net fluid loss. Plasma AVP remained constant during ANP infusions but increased significantly afterwards when plasma ANP concentrations were falling rapidly, and this was accompanied by marked antidiuresis. PRA fell by 23% during the saline control infusions and by 50% during ANP infusions. Following cessation of ANP infusions there was a significant rebound increase in PRA. No changes were observed in blood pressure, heart rate, glomerular filtration rate or renal plasma flow. These results suggest an interaction in man between ANP and the hormones renin and AVP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966190     DOI: 10.1007/BF03350091

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

3.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.

Authors:  T Maack; D N Marion; M J Camargo; H D Kleinert; J H Laragh; E D Vaughan; S A Atlas
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

4.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

5.  Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria.

Authors:  M G Currie; D M Geller; B R Cole; J G Boylan; W YuSheng; S W Holmberg; P Needleman
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

6.  Effects of synthetic atrial natriuretic factor on renal function and renin release.

Authors:  J C Burnett; J P Granger; T J Opgenorth
Journal:  Am J Physiol       Date:  1984-11

7.  Blood levels and renal effects of atrial natriuretic peptide in normal man.

Authors:  P Weidmann; L Hasler; M P Gnädinger; R E Lang; D E Uehlinger; S Shaw; W Rascher; F C Reubi
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Atrial natriuretic peptide: an endogenous factor enhancing sodium excretion in man.

Authors:  J Anderson; A Struthers; N Christofides; S Bloom
Journal:  Clin Sci (Lond)       Date:  1986-04       Impact factor: 6.124

9.  Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release.

Authors:  W K Samson
Journal:  Neuroendocrinology       Date:  1985-03       Impact factor: 4.914

10.  Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man.

Authors:  J V Anderson; J Donckier; N N Payne; J Beacham; J D Slater; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1987-03       Impact factor: 6.124

View more
  2 in total

1.  Effects of insulin on kidney function and sodium excretion in healthy subjects.

Authors:  P Skøtt; O Hother-Nielsen; N E Bruun; J Giese; M D Nielsen; H Beck-Nielsen; H H Parving
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

2.  Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients.

Authors:  M Hummel; M Kuhn; A Bub; H Bittner; D Kleefeld; P Marxen; B Schneider; R Hetzer; W G Forssmann
Journal:  Clin Investig       Date:  1992-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.